Global Health Science and Practice · 2021 · 13 citations · 31 references
MedicineGeriatric MedicineObstetricsDementiaGeriatric AssessmentGeriatricsComprehensive Geriatric AssessmentDementia DiagnosisDementia EpidemiologyPostpartum AssessmentPostpartum CareBias In Economic EvaluationEconomic Evaluation AppraisalEconomic Performance EvaluationMaternal Health Service UsePostpartum Care UtilizationPostpartum Intrauterine Device PlacementPostpartum Intrauterine Device UseStandardised Measurement Approach
INTRODUCTION: Postpartum family planning is an effective means of achieving improved health outcomes for women and children, especially in low- and middle-income settings. We assessed the cost-effectiveness of an immediate postpartum intrauterine device (PPIUD) initiative compared with standard practice in Bangladesh and Tanzania (which is no immediate postpartum family planning counseling or service provision) to inform resource allocation decisions for governments and donors. METHODS: A decision analysis was constructed to compare the PPIUD program with standard practice. The analysis was based on the number of PPIUD insertions, which were then modeled using the Impact 2 tool to produce estimates of cost per couple-years of protection (CYP) and cost per disability-adjusted life years (DALYs) averted. A micro-costing approach was used to estimate the costs of conducting the program, and downstream cost savings were generated by the Impact 2 tool. Results are presented first for the program as evaluated, and second, based on a hypothetical national scale-up scenario. One-way sensitivity analyses were conducted. RESULTS: The PPIUD initiative was highly cost-effective in Bangladesh and Tanzania, and national scale-up of PPIUD could produce long-term savings in direct health care costs in both countries. These analyses provide a compelling case for national governments and international donors to invest in PPIUD as part of their family planning strategies.
31
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Don Husereau, Michael Drummond, Stavros Petrou et al. · BMJ · 2013 · 1.8K citations · Full text
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
Beth Woods, Paul Revill, Mark Sculpher et al. · Value in Health · 2016 · 925 citations · Full text
Cost–effectiveness thresholds: pros and cons
Melanie Bertram, Jeremy A. Lauer, Kees de Joncheere et al. · Bulletin of the World Health Organization · 2016 · 788 citations · Full text
Pharmacy, Economics, Health Policy +17
John G.F. Cleland, Agustín Conde‐Agudelo, Herbert B. Peterson et al. · The Lancet · 2012 · 783 citations